GORE® EXCLUDER® Iliac Branch Endoprosthesis meer dan duizend keer geïmplanteerd

FLAGSTAFF, Ariz.–(BUSINESS WIRE)– W. L. Gore & Associates, Inc. (Gore) heeft vandaag aangekondigd dat de GORE® EXCLUDER® Iliac Branch Endoprosthesis de grens van duizend implantaten wereldwijd heeft overschreden. De mijlpaal komt slechts twee jaar nadat het apparaat een CE-markering kreeg in Europa. Het product is momenteel algemeen verkrijgbaar in Europa en Australië. De endoprosthesis wordt doorloopt momenteel klinische onderzoeken in de Verenigde Staten en is beperkt verkrijgbaar in Canada.

Het apparaat is het eerste complete systeem voor endovasculaire behandelingen van aneurysma’s in slagaders in de bekken en van aorto-iliacale aneurysma’s. Gore ontwierp een iliacale tak en interne iliacale onderdelen.

GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide

FLAGSTAFF, Ariz.–(BUSINESS WIRE)– W. L. Gore & Associates, Inc. (Gore) today announced that the GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe. The device is currently commercially available in Europe and Australia, in clinical trial in the US, and available through special access in Canada.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151117005075/en/

GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. (Photo: Business Wire)

The device is the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. Used in conjunction with GORE® EXCLUDER® AAA Endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries — the iliac branch device is built on Gore’s proven technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft and nitinol stent combination.

“With traditional EVAR techniques, preserving flow into the internal iliac artery in patients with common iliac artery aneurysms can be very difficult. The availability of a complete EVAR system permitting preservation of pelvic blood flow using an iliac branch device was previously non-existent,” said Darren Schneider, MD, Chief of Vascular and Endovascular Surgery at the Weill Cornell Medical College. “Now, with so many examples of positive outcomes from all over the globe, it is exciting to see more patients have access to the clinical benefits offered by this device.”

The GORE EXCLUDER Iliac Branch Endoprosthesis provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16 Fr introducer sheath for the iliac branch component, and a 12 Fr flexible, reinforced introducer sheath for the internal iliac component.

“Our dedicated components for iliac artery repair continue to provide a complete low profile system for managing common iliac artery aneurysms,” said Ryan Takeuchi, Aortic Business Unit Leader at Gore. “Because of the various configurations, this innovative technical solution is available for choosing the right product for the best individual treatment of the patient.”

The GORE EXCLUDER Iliac Branch Endoprosthesis is part of the growing family of GORE EXCLUDER Device and thoracic Conformable GORE® TAG® Device products that share a mission to effectively treat aortic aneurysms through minimally invasive means, backed by Gore’s highly rated clinical support team and comprehensive educational offerings.

ABOUT VEITHsymposium

Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend VEITHsymposium, please visit  www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780

ABOUT W. L. GORE & ASSOCIATES

At Gore, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the US “100 Best Companies to Work For” lists since the rankings debuted in 1984.

Products listed may not be available in all markets. GORE®, EXCLUDER®, and TAG® are trademarks of W. L. Gore & Associates. AU0711-EN1 NOVEMBER 2015

View source version on businesswire.com: http://www.businesswire.com/news/home/20151117005075/en/

Contacts

Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1 312-997-2436
GoreMedical@Chempetitive.com